Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression

Area of Science:

• Biomaterials Science
• Immunology
• Drug Delivery

Background:

• Systemic immunosuppressants like rapamycin have harmful side effects.
• Targeted delivery of immunosuppressants can mitigate toxicity.
• Phagocytes play a key role in immunosuppression.

Purpose of the Study:

• To develop and optimize rapamycin-loaded polymeric microparticles for targeted immunosuppression.
• To evaluate the degradation properties and efficacy of acetalated dextran (Ac-DEX) microparticles.
• To assess the potential of Ac-DEX microparticles in reducing pro-inflammatory responses.

Main Methods:

• Rapamycin was encapsulated into Ac-DEX microparticles using a single emulsion (water/oil) technique.
• Microparticle synthesis parameters, including polymer molecular weight, were optimized.
• Ac-DEX microparticles were tested in vitro with lipopolysaccharide-stimulated RAW macrophages.

Main Results:

• Ac-DEX microparticles with a molecular weight of 71k showed higher rapamycin encapsulation efficiency and slower degradation.
• RAW macrophages treated with rapamycin-loaded Ac-DEX microparticles demonstrated reduced nitric oxide production.
• Favorable cell viability was observed in macrophages treated with the optimized microparticles.

Conclusions:

• Optimized rapamycin-loaded Ac-DEX microparticles were successfully fabricated.
• Ac-DEX microparticles offer tunable degradation for controlled drug release in immune applications.
• These novel microparticles show promise for future immunosuppressive therapies with reduced toxicity.